ImageneBio Inc. (IMA)
IMA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.24
-0.23% on the day
Market cap
$48.1M
Nano cap
Revenue · 2025
$800K
-77.1% on 2024
Net income · 2025
-$45.3M
-5668.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | IMA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001835579 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $800K |
| Net income | -$45.3M |
| Operating income | -$48.5M |
| Net margin | -5668.6% |
| Operating margin | -6056.4% |
| Revenue growth | -77.1% |
| Cash | $94.5M |
| Total assets | $153.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 60.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-05 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 336 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| ELOX | Eloxx Pharmaceuticals Inc. | $12.70 | -8.57% | $51.3M |
| BKHA | Black Hawk Acquisition Corporation | $12.48 | -4.00% | $51.8M |
| INKT | MiNK Therapeutics Inc. | $10.23 | -2.85% | $52.2M |
| KLRS | Kalaris Therapeutics Inc. | $2.23 | -1.33% | $53.1M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
| BSEM | BioStem Technologies Inc. | $2.25 | -7.79% | $42.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier